(Q57312501)

English

2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy De

article published 27 August 2010 in European Heart Journal

In more languages

Statements

scholarly article

0 references

2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy De (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

Christian Funck-Brentano

object named as

C. Funck-Brentano

18

0 references

object named as

C. Ceconi

15

0 references

Zbigniew Kalarus

object named as

Z. Kalarus

35

0 references

Piotr Ponikowski

object named as

P. Ponikowski

8

0 references

Per Anton Sirnes

25

object named as

P. A. Sirnes

0 references

37

object named as

K. Swedberg

0 references

6

object named as

C. Linde

0 references

Michał Tendera

26

object named as

M. Tendera

0 references

Michał Tendera

29

object named as

M. Tendera

0 references

Stefan D. Anker

30

object named as

S. D. Anker

0 references

Kenneth Dickstein

2

object named as

K. Dickstein

0 references

33

object named as

A. W. Hoes

0 references

38

object named as

A. J. Camm

0 references

19

object named as

R. Hobbs

0 references

author name string

P. E. Vardas

3

0 references

A. Auricchio

4

0 references

J.-C. Daubert

5

0 references

J. McMurray

7

0 references

S. G. Priori

9

0 references

R. Sutton

10

0 references

D. J. van Veldhuisen

11

0 references

A. Vahanian

12

0 references

A. Auricchio

13

0 references

J. Bax

14

0 references

V. Dean

16

0 references

G. Filippatos

17

0 references

P. Kearney

20

0 references

T. McDonagh

21

0 references

B. A. Popescu

22

0 references

Z. Reiner

23

0 references

U. Sechtem

24

0 references

P. Vardas

27

0 references

P. Widimsky

28

0 references

J.-J. Blanc

31

0 references

M. Gasparini

32

0 references

C. W. Israel

34

0 references

B. Merkely

36

0 references

publication date

27 August 2010

0 references

European Heart Journal

0 references

31

0 references

21

0 references

2677-2687

0 references

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

The current cost of heart failure to the National Health Service in the UK.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Systematic review: cardiac resynchronization in patients with symptomatic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Cardiac-resynchronization therapy for the prevention of heart-failure events.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

The European cardiac resynchronization therapy survey.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Biventricular pacing in patients with bradycardia and normal ejection fraction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Advanced heart failure treated with continuous-flow left ventricular assist device.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Pacing Therapies in Congestive Heart Failure II study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Long-Term Effects of Upgrading to Biventricular Pacing: Differences with Cardiac Resynchronization Therapy as Primary Indication

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ337

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHQ337

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57312501&oldid=1859184053"